AnaptysBio Inc to Provide Overview of Rosnilimab, a PD1 Agonist, at Virtual R&D Event - Final

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Fair Disclosure Wire (Quarterly Earnings Reports). 10/25/2023.